RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mohamed A. Bayorh to Spironolactone

This is a "connection" page, showing publications Mohamed A. Bayorh has written about Spironolactone.
Connection Strength

1.434
  1. Bayorh M, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D. Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase. J Renin Angiotensin Aldosterone Syst. 2012 Sep; 13(3):353-9.
    View in: PubMed
    Score: 0.416
  2. Bayorh MA, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D. Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4. J Renin Angiotensin Aldosterone Syst. 2011 Sep; 12(3):195-201.
    View in: PubMed
    Score: 0.382
  3. Eatman D, Layas MF, Bayorh MA. Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney. Kidney Blood Press Res. 2010; 33(3):167-73.
    View in: PubMed
    Score: 0.366
  4. Bayorh MA, Mann G, Walton M, Eatman D. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats. Clin Exp Hypertens. 2006 Feb; 28(2):121-32.
    View in: PubMed
    Score: 0.270
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support